Relmada Therapeutics, Inc.
Relmada Therapeutics, Inc.
Your view on RLMD
Overview
What the company does, where it operates, and who runs it.
About Relmada Therapeutics, Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Sergio Traversa
- Headquarters
- 2222 Ponce de Leon Boulevard, Coral Gables, FL, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Sergio Traversa
- Headquarters
- 2222 Ponce de Leon Boulevard, Coral Gables, FL, US
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder in adults. The company was founded in 2004 and is headquartered in Coral Gables, Florida.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.